2017 Annual Report Website
Live Vaccines
COMPOSITION
PNEUMOMUNE™ is a patented modified live Avian Pneumovirus vaccine
for use in turkeys and is supplied in a freeze-dried preparation. The Avian
Pneumovirus contained in this vaccine is classified as a subgroup C isolate.
INDICATIONS
This vaccine is used to elicit immunity against a highly contagious upper
respiratory tract disease of turkeys, commonly referred to as turkey
rhinotracheitis. This respiratory disease is characterized by nasal discharge,
sneezing, swelling of the infraorbital sinuses, foamy conjunctivitis, air
sacculitis and mortality. Severity of disease in growing turkeys is exacerbated
in the presence of secondary pathogens. In laying turkeys, Pneumovirus
Infection is associated with a drop in egg production.
ADMINISTRATION AND DOSAGE
PNEUMOMUNE™ is recommended for vaccination of healthy turkeys at one
week of age or older. Revaccination is recommended approximately 4-6 weeks
after initial vaccination. Additional revaccinations at timely intervals are warranted
in high risk situations and in older turkeys.
PNEUMOMUNE™ may be administered in the drinking water, by eye drop or by aerosol spray.
PNEUMOMUNE™ may be administered in the drinking water, by eye drop or by aerosol spray.
STORAGE
Store this vaccine at 35-45°F
(2-7°C).
PACKAGED
10 x 2,000 doses vials / box
10 x 5,000 doses vials / box
10 x 5,000 doses vials / box
GENERAL REMINDER: Product indications, usage instructions & withdrawal periods may vary by Country. Always follow label instructions and consult your veteriarian or poultry health adviser. |
This page contains information on veterinary pharmaceutical and biological products that are sold in several different countries and areas where they may be marketed under different trade names and pursuant to different regulatory approvals. Accordingly, ThePoultrySite and CEVA SANTE ANIMALE give no guarantee that the details presented are correct with respect to all locations.
|